Perspective: Highlights from the University of California San Diego Center for AIDS research

AIDS Research and Human Retroviruses

Volumn 13, Issue 2, 1997, Pages 117-120

  Wong Staal, Flossie ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; REVIEW; UNITED STATES; AIDS RELATED COMPLEX; ANTIBIOTIC RESISTANCE; DRUG DESIGN; GENE THERAPY; HUMAN; PHYSIOLOGY; UNIVERSITY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEF PROTEIN;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS VACCINES; AIDS-RELATED OPPORTUNISTIC INFECTIONS; APOPTOSIS; CALIFORNIA; DRUG DESIGN; DRUG RESISTANCE, MICROBIAL; GENE PRODUCTS, NEF; GENE THERAPY; HIV-1; HUMANS; UNIVERSITIES;

EID: 0031579072     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.117     Document Type: Review

References (30)

1. Cullen BR: The role of Nef in the replication cycle of the human and simian immunodeficiency viruses. Virology 1994;205:1-6.
2. Krestler HW III, Ringler DJ, Mori K, Panicali DL, Sehgal KP, Daniel MD, and Desrosiers RC: Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991;65:651-662.
3. Miller WD, Warmerdam MT, Gaston I, Greene WC, and Feinberg MB: The human immunodeficiency virus-1 nef gene product. A positive factor for the viral infection and replication in primary lymphocytes and macrophages. J Exp Med 1994;179:101-113.
4. Chowers MY, Spina CA, Kwoh TJ, Fitch NJS, Richman DD, and Guatelli JC: Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J Virol 1994;68:2906-2914.
5. Spina CA, Kwoh TJ, Chowers MY, Guatelli JC, and Richman DD: The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J Exp Med 1994;179:115-123.
6. Garcia JV and Miller AD: Serine phosphorylation-independent downregulation of CD4 by Nef. Nature 1991;350:508-511.
7. Chowers MY, Pandori MW, Spina CA, Richman DD, and Guatelli JC: The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation. Virology 1995;212:451-457.
8. Aiken C and Trono D: Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J Virol 1995;69:5048-5056.
9. Pandori MW, Fitch NJ, Craig HM, Richman DD, Spina CA, and Guatelli JC: Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J Virol 1996;70: 4283-4290.
10. Laurent-Crawford AG, Krust B, Muller S, Riviere MA, Bechet JM, Montagnier L, and Hovanesian AG: The cytopathic effect of HIV is associated with apoptosis. Virology 1991;185:829-839.
11. Terai C, Kornbluth RS, Pauza CD, Richman DD, and Carson DA: Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 1991;87:1710-1715.
12. Corbeil J, Tremblay M, and Richman DD: HIV-induced apoptosis requires the CD4 receptor cytoplasmic tail and is accelerated by interaction of CD4 with p56. J Exp Med, 1996;183:39-48.
13. McClure J, Scheibel M, Anderson D, Steele J, Misker L, Morton WR and Hu S-L: Pathogenicity and infectivity of HIV-2 in macaques. Tenth International Conference on AIDS. Yokohama, Japan. Abstract presented session 193A, 1994.
14. Looney DJ, McClure J, Kent S, Radaelli A, Kraus G, Schmidt A, Steffy K, Hu S-L, Morton W and Wong-Staal F: An HIV-2 live-virus vaccine reduces viral replication and protects from disease in M. nemestrina. Submitted.
15. Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen M-D, Silverman G, Lotz M, Carson D, and Raz E: Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996;273:352-354.
16. Richman DD: HIV therapeutics. Science 1996;272:1886-1888.
17. Moutouh L, Corbeil J, and Richman DD: Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure. Proc Natl Acad Sci USA 1996;93:6106-6111.
18. Kozal MJ, Shah N, Shen N, Yang R, Fucini R, Merigan TC, Richman DD, Morres D, Hubbell E, Chee M and Gingeras TR: Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays. Nature Med. 1996; 2:753-759.
19. Yamada O, Yu M, Yee J-K, Kraus G, Looney DJ, and Wong-Staal F: Intracellular immunization of human T-cells with a hairpin ribozyme against human immunodeficiency virus type 1. Gene Ther 1994;1:39-45.
20. Leavitt M, Yu M, Yamada O, Kraus G, Looney D, Poeschla E, and Wong-Staal F: Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes. Hum Gene Ther 1994;5:1115-1120.
21. Leavitt MC, Yu M, Wong-Staal F, and Looney D: Prelude to a ribozyme gene therapy trial. Gene Ther 1996;3:599-606.
22. Yu M, Leavitt M, Maruyama M, Yamada O, Young D, Ho A, and Wong-Staal F: Intracellular immunization of human hematopoietic stem cells with a ribozyme against HIV-1. Proc Natl Acad Sci USA 1995;92:699-703.
23. Yamada O, Kraus G, Luznik L, Yu M, and Wong-Staal F: A chimeric HIV-1 minimal RRE/ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1. J Virol 1996;70:1596-1601.
24. Gervaix A, Li X, Kraus G, and Wong-Staal F: Multigene antiviral vectors inhibit diverse HIV-1 clades. J Virol 1996 (in press).
25. Yamada O, Kraus G, Sargueil B, Yu Q, Burke JM, and Wong-Staal F: Conservation of a hairpin ribozyme target sequence in HIV-1 is required for efficient viral replication. Virology 1996;220:361-366.
26. Poeschla E, Corbeau P and Wong-Staal F: Development of HIV vectors for anti-HIV gene therapy. Proc Natl Acad Sci USA 1996; 93:11395-11399.
27. Corbeau P, Kraus G, and Wong-Staal F: Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line. Proc Natl Acad Sci USA 1996 (in press).
28. Shinkai M and Spector SA: Quantitation of human cytomegalovirus (HCMV) DNA in cerebrospinal fluid by competitive PCR in AIDS patients with different HCMV central nervous system diseases. Scand J Infect Dis 1995;278:559-561.
29. Spector SA, Hsia K, Wolf D, Shinkai M. and Smith I: Molecular detection of human cytomegalovirus and determination of genotypic ganciclovir resistance in clinical specimens. Clin Infect Dis 1995;21:S170-173.
30. Smith IL, Shinkai M, Freeman WR, and Spector SA: Polyradiculopathy associated with ganciclovir-resistant cytomegalovirus in an AIDS patient: Phenotypic and genotypic characterization of sequential virus isolates. J Infect Dis 1996; 173:1481-1484.